Holiday Sale | Save 50%
SubscribeLogin
Holiday Sale | Save 50%
Published

Lupin Acquires Trademarks For Three Diabetes Drugs From Germany's Boehringer Ingelheim

Summary by NDTV Profit
Lupin Ltd. on Friday said it has acquired trademarks of three anti-diabetes medications from German pharmaceutical company Boehringer Ingelheim. According to the company's exchange filing, the acquisition of the three trademarks—Gibtulio, Gibtulio Met, and Ajaduo—will enable it to offer a wider range of diabetes treatments in India. However, it did not mention the transaction value.“This acquisition is a key step in strengthening our diabetes po…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

BusinessBusiness
FinanceFinance
MumbaiMumbai
India EconomyIndia Economy
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal